TumorDiagnostik & Therapie, Table of Contents TumorDiagnostik & Therapie 2013; 34(5): 258-261DOI: 10.1055/s-0032-1319721 Schwerpunkt: Lymphatische Neoplasien bei Kindern und Jugendlichen Georg Thieme Verlag KG Stuttgart · New YorkÜbersicht – Non-Hodgkin-Lymphome bei Kindern und Jugendlichen B. BurkhardtRecommend Article Abstract Buy Article Full Text References Literatur 1 Brugieres L, Le Deley MC, Rosolen A et al. Impact of the methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: results of a randomized trial of the EICNHL Group. J Clin Oncol 2009; 27: 897-903 2 Burkhardt B, Woessmann W, Zimmermann M et al. Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma. J ClinOncol 2006; 24: 491-499 3 Reiter A, Schrappe M, Parwaresch R et al. Non-Hodgkin‘s lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage—a report of the Berlin-Frankfurt-Munster Group. JClinOncol 1995; 13: 359-372 4 Woessmann W, Seidemann K, Mann G et al. The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood 2005; 105: 948-958 5 Burkhardt B, Zimmermann M, Oschlies I et al. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol 2005; 131: 39-49 6 Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin‘s lymphomas: dissimilarities from lymphomas in adults. SeminOncol 1980; 7: 332-339 7 Burkhardt B, Reiter A, Landmann E et al. Poor Outcome for Children and Adolescents With Progressive Disease or Relapse of Lymphoblastic Lymphoma: A Report From the Berlin-Frankfurt-Muenster Group. J Clin Oncol 2009; 27: 3363-3369 8 Woessmann W. Re-induction approaches to relapsed/refractory childhood and adolescent non Hodgkin¢s lymphoma: BFM perspective. Br J Haematol 2012; 159: 39 9 Woessmann W, Zimmermann M, Lenhard M et al. Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-Frankfurt-Muenster (BFM)-type first-line therapy: a BFM-group study. J Clin Oncol 2011; 29: 3065-3071 10 Meinhardt A, Burkhardt B, Zimmermann M et al. Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin‘s lymphoma and Burkitt leukemia. J Clin Oncol 2010; 28: 3115-3121
